Table 20 Antitumor potential results of compounds b13 and b14
From: Therapeutic potential of heterocyclic pyrimidine scaffolds
Compounds | Human leukaemia (HL-60) cancer cell IC50 = µmol/l |
|---|---|
b13 | 0.08 |
b14 | 0.21 |
Doxorubicin | 0.55 |
From: Therapeutic potential of heterocyclic pyrimidine scaffolds
Compounds | Human leukaemia (HL-60) cancer cell IC50 = µmol/l |
|---|---|
b13 | 0.08 |
b14 | 0.21 |
Doxorubicin | 0.55 |